Effect of hepatocyte growth factor on endogenous hepatocarcinogenesis in rats fed a choline-deficient L-amino acid-defined diet

Oncology Reports

Volumn 16, Issue 1, 2006, Pages 25-31

  Nakanishi, Chihiro ^a   Moriuchi, Akihiro ^b   Ido, Akio ^b   Numata, Masatsugu ^a,b   Kim, Il Deok ^b   Kusumoto, Kazunori ^a   Hasuike, Satoru ^a   Abe, Hiroo ^a   Nagata, Kenji ^a   Akiyama, Yutaka ^a   Uto, Hirofumi ^a   Kataoka, Hiroaki ^a   Tsubouchi, Hirohito ^a,b,c  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Choline deficient; Hepatocarcinogenesis; Hepatocyte growth factor; L amino acid

Indexed keywords

ALBUMINOID; AMINO ACID; CHOLINE; RECOMBINANT PROTEIN; SCATTER FACTOR;

ANIMAL; ANIMAL FOOD; ARTICLE; FISCHER 344 RAT; HUMAN; LIVER TUMOR; LUNG TUMOR; MALE; METABOLISM; METASTASIS; PHYSIOLOGY; RAT;

ALBUMINS; AMINO ACIDS; ANIMAL FEED; ANIMALS; CHOLINE; HEPATOCYTE GROWTH FACTOR; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; NEOPLASM METASTASIS; RATS; RATS, INBRED F344; RECOMBINANT PROTEINS;

EID: 33750728896     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.1.25     Document Type: Article

References (45)

1. Gohda E, Tsubouchi H, Nakayama H, et al: Human hepatocyte growth factor in plasma from patients with fulminant hepatic failure. Exp Cell Res 166: 139-150, 1986. (Pubitemid 16030464)
2. Gohda E, Tsubouchi H, Nakayama H, et al: Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 81: 414-419, 1988. (Pubitemid 18075233)
3. Michalopoulos GK: Liver regeneration: molecular mechanisms of growth control. FASEB J 4: 176-185, 1990.
4. Dignass AU, Lynch-Devaney K and Podolsky DK: Hepatocyte growth factor/scatter factor modulates intestinal epithelial cell proliferation and migration. Biochem Biophys Res Commun 202: 701-709, 1994. (Pubitemid 24259271)
5. Bussolino F, Di Renzo MF, Ziche M, et al: Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119: 629-641, 1992.
6. Zarneger R and Michalopoulos GK: The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 129: 1177-1180, 1995.
7. Fujiwara K, Nagoshi S, Ohno A, et al: Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology 18: 1443-1449, 1993. (Pubitemid 23348435)
8. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K and Nakamura T: Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 16: 1227-1235, 1992.
9. Ishii T, Sato M, Sudo K, et al: Hepatocyte growth factor stimulates liver regeneration and elevates blood protein level in normal and partially hepatectomized rats. J Biochem 117: 1105-1112, 1995.
10. Webber EM, FitzGerald MJ, Brown PI, Barlett MH and Fausto N: Transforming growth factor-α expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between transforming growth factor-α and hepatocyte growth factor. Hepatology 18: 1422-1431, 1993.
11. Moriuchi A, Hirono S, Ido A, et al: Additive and inhibitory effects of simultaneous treatment with growth factors on DNA synthesis through MAPK pathway and G1 cyclins in rat hepatocytes. Biochem Biophys Res Commun 280: 368-273, 2001.
12. Okano J, Shiota G and Kawasaki H: Protective action of hepatocyte growth factor for acute liver injury caused by D-galacto-samine in transgenic mice. Hepatology 26: 1241-1249, 1997. (Pubitemid 27509309)
13. Kosai K, Matsumoto K, Nagata S, Tsujimoto Y and Nakamura T: Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem Biophys Res Commun 244: 683-690, 1998. (Pubitemid 28418128)
14. Masunaga H, Fujise N, Shiota A, et al: Preventive effects of the deleted form of hepatocyte growth factor against various liver injuries. Eur J Pharmacol 342: 267-279, 1998. (Pubitemid 28149979)
15. Kosai K, Matsumoto K, Funakoshi H and Nakamura T: Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure. Hepatology 30: 151-159, 1999. (Pubitemid 29300581)
16. Mori I, Tsuchida A, Taiji M and Noguchi H: Hepatocyte growth factor protects mice against anti-Fas antibody-induced death. Med Sci Res 27: 355-359, 1999. (Pubitemid 29253640)
17. Nomi T, Shiota G, Isono M, Sato K and Kawasaki H: Adenovirus-mediated hepatocyte growth factor gene transfer prevents lethal liver failure in rats. Biochem Biophys Res Commun 278: 338-343, 2000.
18. Xue F, Takahara T, Yata Y, et al: Attenuated acute liver injury in mice by naked hepatocyte growth factor gene transfer into skeletal muscle with electroporation. Gut 50: 558-562, 2002. (Pubitemid 34638878)
19. Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T and Higashio K: Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 24: 636-642, 1996. (Pubitemid 26296009)
20. Matsuda Y, Matsumoto K, Yamada A, et al: Prevention and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology 26: 81-89, 1997. (Pubitemid 27280310)
21. Ueki T, Kaneda Y, Tsutsui H, et al: Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 5: 226-230, 1999. (Pubitemid 29068532)
22. Sato M, Kakubari M, Kawamura M, Sugimoto J, Matsumoto K and Ishii T: The decrease in total collagen fibers in the liver by hepatocyte growth factor after formation of cirrhosis induced thioacetamide. Biochem Pharmacol 59: 681-690, 2000. (Pubitemid 30085450)
23. Oe S, Fukunaka Y, Hirose T, Yamaoka Y and Tabata Y: A trial on regeneration therapy of rat liver cirrhosis by controlled release of hepatocyte growth factor. J Control Release 307: 146-151, 2003.
24. Tsubouchi H, Niitani Y, Hirono S, et al: Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 13: 1-5, 1991.
25. Tsubouchi H, Kawakami S, Hirono S, et al: Prediction of outcome in fulminant hepatic failure by serum human hepatocyte growth factor. Lancet 340: 307, 1992.
26. Ido A, Moriuchi A, Kim ID, et al: Pharmacokinetic study of recombinant human hepatocyte growth factor administered in a bolus intravenously or via portal vein. Hepatol Res 30: 175-181, 2004. (Pubitemid 39654749)
27. Nakae D, Yoshiji H, Mizumoto Y, et al: High incidence of hepatocellular carcinomas induced by a choline-deficient, L-amino acid-defined diet in rats. Cancer Res 52: 5042-5045, 1992.
28. Onaga M, Ido A, Hasuike S, et al: Enhanced expression of growth factors and imbalance between hepatocyte proliferation and apoptosis in the livers of rats fed a choline-deficient, L-amino acid-defined diet. Hepatol Res 28: 94-101, 2004. (Pubitemid 38181628)
29. Maronpot RR, Montgomery CA, Boorman GA and McConnell EE: National toxicology program nomenclature for hepatoproliferative lesions of rats. Toxicol Pathol 14: 263-273, 1986. (Pubitemid 16016994)
30. Sakata H, Takayama H, Sharp R, Rubin JS, Merlino G and LaRochelle WJ: Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers. Cell Growth Differ 7: 1513-1523, 1996. (Pubitemid 26378346)
31. Takayama H, LaRochelle, Sharp R, et al: Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci USA 94: 701-706, 1997.
32. Gallego MI, Bierie B and Hennighausen L: Targeted expression of HGF/SF in mouse mammary epithelium leads to metastatic adenosquamous carcinomas through the activation of multiple signal transduction pathways. Oncogene 22: 8498-8508, 2003. (Pubitemid 37523901)
33. Bell A, Chen Q, DeFrances MC, Michalopoulos GK and Zarnegar R: The five amino acid-deleted isoform of hepatocyte growth factor promotes carcinogenesis in transgenic mice. Oncogene 18: 887-895, 1999. (Pubitemid 29086265)
34. Horiguchi N, Takayama H, Toyoda M, et al: Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine. Oncogene 21: 1791-1799, 2002. (Pubitemid 34259181)
35. Nooman FP, Otsuka T, Bang S, Anver MR and Merlino G: Accelerated ultraviolet radiation-induced carcinogenesis in hepatocyte growth factor/scatter factor transgenic mice. Cancer Res 60: 3738-3743, 2000. (Pubitemid 32204561)
36. Shiota G, Kawasaki H, Nakamura T and Schmidt EV: Characterization of double transgenic mice expressing hepatocyte growth factor and transforming growth factor α. Res Commun Mol Pathol Pharmacol 90: 17-24, 1995.
37. Santoni-Rugiu E, Preisegger KH, Kiss A, et al: Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model. Proc Natl Acad Sci USA 93: 9577-9582, 1996. (Pubitemid 26296650)
38. Shima N, Nagao M, Ogaki F, Tsuda E, Murakami A and Higashio K: Tumor cytotoxic factor/hepatocyte growth factor from human fibroblasts: cloning of its cDNA, purification and characterization of recombinant protein. Biochem Biophys Res Commun 180: 1151-1158, 1991.
39. Liu ML, Mars WM and Michalopoulos GK: Hepatocyte growth factor inhibits cell proliferation in vivo of rat hepatocellular carcinomas induced by diethylnitrosamine. Carcinogenesis 16: 841-843, 1995.
40. Ogasawara H, Hiramoto J, Takahashi M, et al: Hepatocyte growth factor stimulates DNA synthesis in rat preneoplastic hepatocytes but not in liver carcinoma cells. Gastroenterology 114: 775-781, 1998. (Pubitemid 28160412)
41. Yaono M, Hasegawa R, Mizoguchi Y, et al: Hepatocyte growth factor enhancement of preneoplastic hepatic foci development in rats treated with diethylnitrosamine and N-ethyl-N-hydroxyethylnitrosamine. Jpn J Cancer Res 86: 718-723, 1995.
42. Arakaki N, Kazi JA, Kazihara T, Ohnishi T and Daikuhara Y: Hepatocyte growth factor/scatter factor activates the apoptosis signaling pathway by increasing caspase-3 activity in sarcoma 180 cells. Biochem Biophys Res Commun 245: 211-215, 1998. (Pubitemid 28414272)
43. Gohda E, Okauchi H, Iwao M and Yamamoto I: Induction of apoptosis by hepatocyte growth factor/scatter factor and its augmentation by phorbol esters in Meth A cells. Biochem Biophys Res Commun 245: 278-283, 1998. (Pubitemid 28414284)
44. Arakaki N, Kajihara T, Akakaki R, et al: Involvement of oxidative stress in tumor cytotoxic activity of hepatocyte growth factor/scatter factor. J Biol Chem 274: 13541-13546, 1999.
45. Kusumoto K, Ido A, Moriuchi A, et al: Repeated intravenous injection of recombinant human hepatocyte growth factor ameliorates liver cirrhosis but causes albuminuria in rats. Int J Mol Med 17: 503-509, 2006.